This inventor holds 1 USPTO granted patent. Top assignees: Korea Greencross Corporation, Pohang University of Science and Technology Foundation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 16 
1 out of 1,108 Years Active: 2007
Title: Chi Bom Chae: Innovator in Anti-Angiogenesis Peptides
Introduction
Chi Bom Chae is a notable inventor based in Kyungsangbukdo, South Korea, recognized for his contribution to the field of biochemistry through the development of innovative peptides. With a focus on combating angiogenesis-related diseases, his work plays a crucial role in advancing cancer treatment and other disease therapies.
Latest Patents
Chi Bom Chae holds a patent for "Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis." This patent describes novel peptides designed to inhibit the activity of vascular endothelial growth factor (VEGF). By blocking VEGF from binding to its cell surface receptors, these peptides help to prevent the angiogenesis that fuels tumor growth. The research involved creating a combinatorial library of six amino acid residues, which were screened to identify the most effective peptide sequences. The results indicate that these peptides significantly hinder tumor growth and metastasis in animal models while potentially offering therapeutic benefits for conditions such as diabetic retinopathy and rheumatoid arthritis.
Career Highlights
Chi Bom Chae has had a significant impact through his work at various esteemed organizations. He has been associated with Korea Greencross Corporation, a prominent biotechnology company, and Postech Foundation, which focuses on advancing scientific research and technology.
Collaborations
Throughout his career, Chi Bom Chae has collaborated with talented individuals, including Dong Goo Bae and Wan Hee Yoon. Such teamwork highlights the collaborative nature of scientific research, allowing for the exchange of ideas and the development of innovative solutions to complex medical issues.
Conclusion
Chi Bom Chae's groundbreaking work in developing peptide-based treatments represents a significant advancement in the fight against cancer and other angiogenesis-related diseases. His patent showcases the potential of innovative therapies that can alter the course of these complex conditions, confirming his status as a notable figure in the field of biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile